Coralite Muscle And Joint Pain Relief Liquid
NDC Package 65923-161-40
Package Information
Coralite Muscle And Joint Pain Relief (capsacin) liquids is directionsadults and children over 18 years:apply to affected areaplace the applicator on the skin and press firmly to dispense the liquidmassage into painful area until thoroughly absorbedrepeat if necassary, but no more than 3 to 4 times dailyIF MEDICINE COMES IN CONTACT WITH HANDS, WASH WITH SOAP AND WATERchildren 17 years or younger: consult a physician. This formulation utilizes a liquid delivery system. Marketed by United Exchange Corp., this product is identified by NDC 65923-161 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 792051 - capsaicin 0.15 % Topical Solution
- RxCUI: 792051 - capsaicin 1.5 MG/ML Topical Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65923 - United Exchange Corp.
- 65923-161 - Coralite Muscle And Joint Pain Relief
- 65923-161-40 - 1 BOTTLE, WITH APPLICATOR in 1 BOX / 40 mL in 1 BOTTLE, WITH APPLICATOR
- 65923-161 - Coralite Muscle And Joint Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65923-161-40 identifies a specific commercial package of 1 bottle, with applicator in 1 box / 40 ml in 1 bottle, with applicator of Coralite Muscle And Joint Pain Relief, a human over the counter drug labeled by United Exchange Corp.. This liquid is formulated for topical use and contains capsaicin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by United Exchange Corp. on May 08, 2015. The current certification is valid through December 31, 2026.
How is this United Exchange Corp. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65923016140. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.